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MaOBJECTIVES The goal of this study was to assess procedural details and outcomes of repeat MitraClip therapy.
BACKGROUND MitraClip implantation is a safe and efﬁcacious percutaneous approach to treat signiﬁcant mitral
regurgitation (MR).
METHODS Of 410 inoperable or high surgical risk patients treated with the MitraClip at our institution, 17 (4.1%)
patients, as well as 4 patients initially treated at external institutions, underwent repeat MitraClip procedures. Mean age
of the 21 patients (14 men [67%]) was 77 years; 15 patients (71%) had functional MR.
RESULTS Repeat procedures performed at a median of 6.3 months (range 0.7 to 34 months) after the index
intervention were successful (discharge MR grade #2þ) in 13 patients (62%), with a pronounced difference in
success rate observed between the 13 patients with adequate leaﬂet insertion at the time of the repeat inter-
vention and the 8 patients in whom loss of leaﬂet insertion (LLI) (leaﬂet tear/perforation or partial clip
detachment) was present (11 of 13 [85%] vs. 2 of 8 [25%], respectively). The 21 patients were followed for a
median of 8.5 (interquartile range: 2.3 to 18.6) months; 13 patients (62%), 8 with adequate leaﬂet insertion and
5 with LLI, died during follow-up.
CONCLUSIONS Repeat MitraClip intervention for signiﬁcant recurrent MR appears to be a viable therapeutic
approach in patients in whom leaﬂet insertion into the MitraClip is not compromised. LLI is strongly associated
with repeat procedural failure. (J Am Coll Cardiol Intv 2015;8:1480–9) © 2015 by the American College of
Cardiology Foundation.I n recent years, transcatheter mitral valve repairusing the MitraClip (Abbott Vascular, AbbottPark, Illinois) has become a prevalent approach
to treat signiﬁcant mitral regurgitation (MR) in pa-
tients deemed inoperable or at high surgical risk
(1–3). The technique emulates the surgical “edge-to-
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AB BR E V I A T I O N S
AND ACRONYM S
3D = 3-dimensional
AML = anterior mitral leaﬂet
CI = conﬁdence interval
IQR = interquartile range
LLI = loss of leaﬂet insertion
MR = mitral regurgitation
NYHA = New York Heart
Association
PCD = partial clip detachment
PML = posterior mitral leaﬂet
TEE = transesophageal
echocardiography
= vena contracta area
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1481or degenerative) MR may lead to recurrent regurgi-
tation despite initially successful MitraClip therapy.
On the other hand, loss of leaﬂet insertion (LLI)
into the clip imperatively causes a relapse of MR.
LLI may be the consequence of insufﬁcient leaﬂet
grasping, which predisposes the affected leaﬂet to
slip out of the clip if only a few millimeters of leaﬂet
tissue are captured (the distance between the distal
barb of the gripper and the end of the clip arm is
approximately 1.5 mm [cf. Figure 2 in (6)]); in cases
of initially adequate grasping of both leaﬂets, LLI
is conceivable as a consequence of leaﬂet tear or
perforation (7–9).
The complete loss of connection between a clip and
1 leaﬂet has mostly been referred to as “partial clip
detachment” (PCD) (10–12). The less frequently used
terms “single leaﬂet detachment” (13), “single leaﬂet
device attachment” (2), and “single leaﬂet clip
attachment” (12,14) describe the same pathology. The
disconnection of a clip from both leaﬂets, that is, clip
embolization, has not been reported to date.FIGURE 1 Patient Flow Chart
The study cohort of 21 patients comprised 17 in-house patients (14 with successful, 3 with
failed index procedures) and 4 patients initially treated at external institutions.
SEE PAGE 1490Deﬁning the adequate treatment for MitraClip
failure is challenging, particularly in inoperable or
high surgical risk patients who constitute the vast
majority of “real-life” patients undergoing MitraClip
therapy in Europe. Other than in the EVEREST II
(Endovascular Valve Edge-to-Edge Repair Study)
patient cohort (15), surgery is typically no option
in post-MitraClip patients who were already poor
surgical candidates (or no surgical candidates at
all) pre-MitraClip. Thus, a repeat MitraClip inter-
vention appears to be a reasonable therapeutic
option. Apart from a few case reports on PCD
(10–13), data on the outcomes of repeat intervention
after MitraClip failure are lacking. Therefore, we
have retrospectively assessed procedural details
and factors impacting the acute outcome of, as
well as long-term survival after, repeat MitraClip
intervention.
METHODS
PATIENTS. Between September 2009 and May 2014,
410 patients had been treated at our institution with
MitraClip implantation for signiﬁcant MR. All pa-
tients were considered inoperable or at high surgical
risk by heart team consensus of interventional car-
diologists and cardiac surgeons. Index procedures
were successful (discharge MR grade #2þ) in 365 of
402 patients (90.8%, 95% conﬁdence interval [CI]:
87.5% to 93.4%) in whom discharge echocar-
diograms were available. Repeat MitraClipinterventions were performed in 17 (4.2%) of
the 402 patients as well as in 4 patients
initially treated at external institutions
(Figure 1). The majority (n ¼ 15 [71%]) of
these 21 patients suffered from functional
MR. In-house index procedures had been
regarded as initially successful (discharge
MR severity #2þ) in 14 (82.4%) of the 17
patients, with repeat intervention indicated
because of recurrent symptomatic severe
MR; the indication for the 3 other in-house
repeat interventions (17.6%) was failure of
the index procedure. All repeat in-
terventions were performed by 2 experi-
enced operators (K.-H.K. and U.S.). Baseline
characteristics of the 21 patients are listed in
Table 1.
Index procedures were adjudicated as failures
also in 34 (9%) of the 385 patients who did not
undergo repeat MitraClip treatment. Nineteen (56%)
of those 34 patients were subsequently managed
medically, and 8 (24%) underwent surgical conver-
sion within a median of 12 days. With 4 patients
dying shortly after conversion and another 7 pa-
tients dying without surgical intervention, a total of
11 patients (32%) died within a median of 21 days
after a failed MitraClip intervention.
MITRACLIP IMPLANTATION. The procedural details
of percutaneous mitral valve repair using the
VCA
TABLE 1 Patient Characteristics (N ¼ 21)
Men 14 (66.7)
Age, yrs 76.6  9.8
Age >80 yrs 10 (47.6)
Body mass index, kg/m2 25.1  4.6
Logistic EuroSCORE 22.5  19.0 (n ¼ 17)
Hypertension 17/19 (89.5)
Hyperlipidemia 13/19 (68.4)
Diabetes mellitus 9/19 (47.4)
Pulmonary hypertension 5/18 (27.8)
COPD 2/19 (10.5)
Atrial ﬁbrillation 11/19 (57.9)
Chronic renal impairment* 10/19 (52.6)
Coronary artery disease 14/19 (73.7)
Previous cardiac surgery 5/19 (26.3)
MR etiology at time of index MC procedure
Functional 15 (71.4)
Degenerative 6 (28.6)
Number of clips implanted at index
MC procedure
1 clip 13 (61.9)
2 clips 8 (38.1)
Values are n (%), mean  SD, or n/N (%). *Glomerular ﬁltration rate
<50 ml/min/1.73 m2.
COPD ¼ chronic obstructive pulmonary disease; MC ¼ MitraClip; MR ¼ mitral
regurgitation.
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1482MitraClip have been described before (15). In the
present study, procedural success was deﬁned as MR
severity #2þ at discharge.
ECHOCARDIOGRAPHY. All patients underwent 2-
dimensional transthoracic echocardiography before
and after the repeat intervention. Two- and 3-
dimensional (3D) transesophageal echocardiography
(TEE) was performed during index and repeat
procedures with commercially available echocardio-
graphic systems (iE33, Philips Medical Systems, And-
over, Massachusetts or Vivid E9, GE Vingmed
Ultrasound AS, Horten, Norway). Standard parame-
ters of left ventricular dimension, as well as left and
right ventricular function, were assessed according to
American Society of Echocardiography guidelines
(16). MR grading was based on a previously reported
technique (17).
The anatomic location of the clips was determined
by TEE in the intercommissural view and, if available,
also in the 3D en face view of the mitral valve. Clip
locations at the lateral (P1) and medial (P3) scallops of
the posterior leaﬂet were deﬁned as lateral and
medial, respectively. A clip location involving the
central scallop (P2) was deﬁned as central (a purely
central position) or, if the clip was located close to
either P1 or P3, as centrolateral or mediocentral,
respectively.The 3 echocardiographic scenarios encountered at
the time of the repeat intervention are shown
schematically in Figure 2. They comprise insertion
of both the anterior mitral leaﬂet (AML) and the
posterior mitral leaﬂet (PML) into the clip
(Figure 2A); LLI suggestive of leaﬂet tear/perforation
(Figure 2B); and LLI clearly representing PCD
(Figure 2C).
Leaﬂet length and leaﬂet insertion into the
MitraClip were retrospectively examined at 3 time
points: before MitraClip implantation, at the end of
the index procedure, and at the beginning of the
repeat procedure. All measurements were taken in
diastole using TEE intercommissural and long-axis
views in a simultaneous biplane manner. Leaﬂet
lengths at baseline were measured from hinge point
to leaﬂet tip at the anatomic site of later clip im-
plantation (Figures 3A, 3D, and 3G). At the end of
the index procedure (Figures 3B, 3E, and 3H) and at
the beginning of the repeat procedure (Figures 3C,
3F, and 3I), leaﬂet length outside the MitraClip was
measured either between the hinge point and the
contact point of the leaﬂet with the MitraClip or, if
no contact point was seen at the beginning of the
repeat procedure, between the hinge point and the
tip of the leaﬂet. At the latter 2 time points, the
length of leaﬂet captured inside the clip was
determined by subtracting the leaﬂet length outside
the clip from the corresponding leaﬂet length at
baseline. “Adequate leaﬂet insertion” was consid-
ered present if the length of leaﬂet captured inside
the clip was $5 mm and both leaﬂets inserted into
the atrial aspect of the closed clip arms (Figure 3B,
3E, and 3H).
LLI was established at the beginning of the
repeat procedure if a leaﬂet inserted no longer into
the atrial aspect of the clip, but was seen during
diastole to move along the clip arm toward its
ventricular tip, with a regurgitant jet originating
from the leaﬂet tip. If the leaﬂet tip did not deviate
by >2 mm from the edge of the MitraClip, leaﬂet
tear/perforation was diagnosed (Figure 3F); in the
case of complete diastolic disconnection of one of
the leaﬂets from the clip, PCD was diagnosed
(Figure 3I).
Vena contracta area (VCA) has been shown to be a
measure of the severity of MR, with a cutoff value of
41 mm2 differentiating optimally between moderate
and severe MR (18). VCA of the regurgitant jet was
measured by plane-corrected planimetry in a 3D color
Doppler full volume (QLAB-Version 8.0, Philips
Medical Systems) just before and after repeat Mitra-
Clip implantation.
FIGURE 2 Schematics of the Mitral Valve and Leaﬂet/Clip Connections Encountered at the Time of Repeat Intervention
Schematics of surgical view of mitral valve (left-hand panels) and diastolic transesophageal echocardiography (TEE) long-axis view
(middle panels) along with real diastolic TEE long-axis view (right-hand panels) of leaﬂet/clip connections encountered at the time of repeat
intervention. Dotted vertical line in left-hand panels denotes echo plane shown in middle and right-hand panels. (A) Correct insertion of
both AML and PML into MitraClip (MC). (B) Loss of leaﬂet insertion manifested by tear of AML (arrow in left-hand panel) along edge of
MC results in AML inserting no longer fully into atrial aspect of MC; rather, free AML tip is displaced toward ventricular end of MC (arrow in
right-hand panel). (C) Partial clip detachment manifested by complete disconnection of AML from MC. AML ¼ anterior mitral leaﬂet;
PML ¼ posterior mitral leaﬂet.
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1483ETHICS. Written informed consent was obtained
from all patients.
STATISTICS. Continuous variables are described as
mean  SD if normally distributed, or as median plus
range or interquartile range (IQR) if not. Categorical
variables are described as absolute and relative
frequencies.
RESULTS
PATIENTS AND PROCEDURES. In this cohort of 21
elderly patients who had received either a single
clip (n ¼ 13 [61.9%]) or 2 clips (n ¼ 8 [38.1%]), for
a total of 29 clips, during the index procedure, the
median time between index and repeat procedure
was 6.3 (range 0.7 to 33.7) months. Of the 21
repeat interventions, 13 were eventually successful
and 8 failed. There was no association between
operator and repeat procedural failure rate (4 of 10
vs. 4 of 11).The repeat procedural success rate of 61.9%
(95% CI: 38.4% to 81.9%) was markedly lower than
the 90.8% (95% CI: 87.5% to 93.4%) index procedural
success rate. No apparent baseline differences in
surgical mortality risk or prevalence of comorbidities
were noted between the 13 patients with a successful
repeat intervention and the 8 patients with a
failed repeat intervention (Table 2). During repeat
interventions, a total of 29 additional clips were
implanted, with multiple clips relatively more often
implanted in patients in whom the repeat procedure
eventually failed (Table 3). Total device time, that is,
the time from transseptal puncture to withdrawal of
the clip delivery system from the left atrium, was 55
(IQR: 36 to 85) minutes; it tended to be longer in pa-
tients with a failed repeat intervention than in those
with a successful repeat intervention. Four patients
(2 procedural successes, 2 procedural failures) had
increased mean transmitral pressure gradients at
discharge (6 mm Hg in 1 patient, 7 mm Hg in
3 patients).
FIGURE 3 Measurement of Leaﬂet Lengths in TEE Long-Axis Views at 3 Time Points
(A to C) Patient without loss of leaﬂet insertion at the time of the repeat procedure (P2). Note that free lengths of AML (in yellow) and PML
(in red) at the beginning of the index procedure (P1) are 8 and 7 mm longer, respectively, than lengths at the end of P1; differences in lengths
denote lengths of respective leaﬂet captured inside the MitraClip (MC). Essentially no change in leaﬂet lengths is observed at the beginning of
P2. (D to F) Patient with leaﬂet tear/perforation at the time of P2. Measurements (in red) are given only for the affected PML. Free PML length
at the beginning of P1 is 18 mm. After MC placement (end of P1), 7 mm of PML are captured inside MC and 11 mm of PML outside MC are seen to
insert into atrial aspect of MC. At the beginning of P2, 11 mm of PML still outside MC insert no longer into atrial aspect of MC; rather, distal tip
of PML appears to connect with MC (arrow) a few millimeters toward the ventricular end of MC, indicative of leaﬂet tear/perforation. (G to I)
Patient with partial clip detachment (PCD) at the time of P2. Measurements (in red) are given only for the affected AML. Free AML length at the
beginning of P1 is 35 mm. After MC placement (end of P1), 6 mm of AML are captured inside MC, and 29 mm of AML outside MC are seen to
insert into atrial aspect of MC. At the beginning of P2, roughly the same length of AML (28 mm) is seen completely disconnected from the MC,
indicative of PCD. Abbreviations as in Figure 2.
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1484CLIP LOCATION. Index clips were mostly implanted
in the medial to central location, with only 1 clip
implanted centrolaterally; new clips implanted
during the repeat intervention were also placed pre-
dominantly in the medial to central position; asubstantial percentage (n ¼ 8 [28%; 95% CI: 13% to
47%]) of new clips were placed centrolaterally.
LEAFLET INSERTION. Echocardiography before the
repeat intervention did not identify any quantitative
TABLE 2 Patient Characteristics According to Repeat Procedural Outcome
Successful Repeat
MC Procedure
(n ¼ 13)
Failed Repeat
MC Procedure
(n ¼ 8)
Men 8 (61.5) 6 (75.0)
Age, yrs 76.7  9.9 76.5  10.4
Age >80 yrs 5 (38.5) 5 (62.5)
Body mass index, kg/m2 25.2  4.8 24.9  4.6
Logistic EuroSCORE 24.6  20.7
(n ¼ 9)
20.2  17.9
(n ¼ 8)
Hypertension 11/12 (91.7) 6/7 (85.7)
Hyperlipidemia 8/12 (66.7) 5/7 (71.4)
Diabetes mellitus 7/12 (58.3) 2/7 (28.6)
Pulmonary hypertension 3/10 (30.0) 2/8 (25.0)
Chronic obstructive pulmonary disease 2/12 (16.7) 0/7 (0.0)
Atrial ﬁbrillation 7/12 (58.3) 4/7 (57.1)
Chronic renal impairment* 6/12 (50.0) 4/7 (57.1)
Coronary artery disease 9/12 (75.0) 5/7 (71.4)
Previous cardiac surgery 3/12 (25.0) 2/7 (28.6)
MR etiology at time of index MC procedure
Functional 10 (76.9) 5 (62.5)
Degenerative 3 (23.1) 3 (37.5)
Number of clips implanted at index
MC procedure
1 clip 7 (53.8) 6 (75.0)
2 clips 6 (46.2) 2 (25.0)
Values are n (%), mean  SD, or n/N (%). *Glomerular ﬁltration rate <50 ml/min/1.73 m2.
Abbreviations as in Table 1.
TABLE 3 Procedural Data of Repeat MitraClip Intervention
All Patients
(n ¼ 21)
Successful Repeat
MC Procedure
(n ¼ 13)
Failed Repeat
MC Procedure
(n ¼ 8)
Number of new clips implanted
0 clips 1 (4.8) — 1 (12.5)
1 clip 13 (61.9) 10 (76.9) 3 (37.5)
2 clips 5 (23.8) 2 (15.4) 3 (37.5)
3 clips 2 (9.5) 1 (7.7) 1 (12.5)
Total device time, min* 55 [36–85] 47 [30–82] 82 [54–108]
Values are n (%) or median [IQR]. *Time from transseptal puncture to withdrawal of clip delivery
system from left atrium.
IQR ¼ interquartile range; MC ¼ MitraClip.
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1485variable predictive of procedural outcome (Table 4).
However, it revealed LLI in 8 patients, with 3 of these
meeting the criterion for PCD. The latter 3 patients
had all been treated initially for functional MR, as
had 3 other patients with LLI; the condition was
observed in only 2 patients initially treated for
degenerative MR.
Leaﬂet insertion at the end of the index proce-
dure was found to be adequate in all patients. The
8 patients with LLI underwent the repeat inter-
vention at a median of 6.2 (range 0.7 to 33.7)
months after the index procedure, which was not
different from patients with adequate leaﬂet inser-
tion at the time of the repeat intervention (6.3 [0.7
to 28.1] months). LLI affected the anterior mitral
leaﬂet in 3 cases and the posterior mitral leaﬂet in
5 cases.
TEE measurement of leaﬂet lengths at beginning
and end of the index procedure, as well as at
beginning of the repeat procedure, is shown in
Figure 3 for a patient without LLI, for 1 with leaﬂet
tear/perforation, and for a patient with PCD. Results
for 7 of the 8 patients with LLI (no index procedure
echocardiography was available in 1 external patient)
are given in Table 5. At the end of the index proce-
dure, a median length of 7 mm was captured inside
the clip in leaﬂets later affected by LLI, as well as in
leaﬂets later not affected by LLI, indicative of acute
procedural success. In the time between the index
and repeat procedures, the lengths of both affected
and unaffected leaﬂets had essentially not changed
(minor, 1-mm differences in AML length were
measured in 3 patients [Table 5]). Therefore, a slip-
ping of the affected leaﬂet out of the clip as the
underlying mechanism of LLI was ruled out in our
patients.
Transthoracic echocardiography in in-house pa-
tients initially treated for functional MR revealed that
left ventricular volumes tended to be markedly
larger, at both the index and the repeat procedure, in
patients with LLI than in those with adequate leaﬂet
insertion (Table 6). In the latter patients, median
volumes had noticeably increased during the period
between index and repeat interventions, presumably
reﬂecting progression of the underlying ventricular
disease. By contrast, median ventricular volumes
were hardly different at the 2 time points in patients
with LLI.
As shown in Table 4 and Figure 4, LLI impacted the
outcome of the repeat intervention such that its
absence was associated with a success rate of 84.6%
(95% CI: 54.6% to 98.1%), whereas its presence
entailed a success rate of only 25.0% (95% CI: 3.2% to
65.1%). The 2 successfully treated among the latterpatients had both presented with leaﬂet tear/perfo-
ration; no patient with PCD could be treated suc-
cessfully. Compared with the index procedural
success rate of 90.8%, the repeat procedural success
rate was on the same order of magnitude in the 13
patients with adequate leaﬂet insertion (90.8% vs.
84.6%), yet clearly lower in the 8 patients with LLI
(90.8% vs. 25.0%).
Total repeat procedural device time tended to be
lower in patients with adequate leaﬂet insertion
TABLE 4 Echocardiographic Variables
All Patients
(N ¼ 21)
Successful Repeat
MC Procedure
(n ¼ 13)
Failed Repeat
MC Procedure
(n ¼ 8)
Before repeat MC procedure
MR severity
3þ 5 (23.8) 4 (30.8) 1 (12.5)
4þ 16 (76.2) 9 (69.2) 7 (87.5)
Evaluation of leaﬂets and clips at
index MC procedure
Adequate leaﬂet insertion 13 (61.9) 11 (84.6) 2 (25.0)
LLI 8 (38.1) 2 (15.4) 6 (75.0)
LV end-diastolic diameter, mm 59 [52–70]
(n ¼ 11)
59 [54–67]
(n ¼ 9)
62 [48–75]
(n ¼ 2)
LV end-systolic diameter, mm 48 [42–58]
(n ¼ 8)
48 [43–58]
(n ¼ 6)
48 [28–68]
(n ¼ 2)
LV end-diastolic volume, ml 154 [100–194]
(n ¼ 15)
154 [111–198]
(n ¼ 11)
174 [66–286]
(n ¼ 4)
LV end-systolic volume, ml 100 [43–134]
(n ¼ 15)
100 [53–130]
(n ¼ 11)
104 [23–212]
(n ¼ 4)
LV ejection fraction, % 35 [28–58]
(n ¼ 15)
35 [28–52]
(n ¼ 11)
48 [26–65]
(n ¼ 4)
Mitral valve area (PHT), cm2 2.9 [2.7–3.5]
(n ¼ 13)
2.9 [2.4–3.6]
(n ¼ 8)
2.9 [2.8–3.1]
(n ¼ 5)
Mitral valve area (TEE), cm2 3.1 [2.5–3.5]
(n ¼ 15)
3.0 [2.4–3.3]
(n ¼ 8)
3.4 [2.8–4.2]
(n ¼ 7)
Mean gradient, mm Hg 3.2 [2.6–4.0]
(n ¼ 18)
3.0 [2.7–3.8]
(n ¼ 12)
3.5 [2.0–4.0]
(n ¼ 6)
Systolic PAP, mm Hg 44 [36–55]
(n ¼ 16)
47 [38–59]
(n ¼ 11)
40 [32–47]
(n ¼ 5)
TAPSE, mm 16 [14–18]
(n ¼ 14)
16 [14–19]
(n ¼ 10)
18 [16–18]
(n ¼ 4)
Vena contracta area, mm2 66 [40–96]
(n ¼ 12)
50 [30–91]
(n ¼ 7)
90 [53–99]
(n ¼ 5)
Continued on the next page
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1486(48 [30 to 88] min) than in patients with LLI (68
[45 to 84] min).
LLI was present in 5 (38.5%) of the 13 patients
initially implanted with 1 clip and 3 (37.5%) of the
8 patients initially implanted with 2 clips. Repeat
procedural success rates in patients initially implan-
ted with 1 and 2 clips were 53.8% and 75.0%,
respectively.
VENA CONTRACTA AREA. VCA was available before
and after repeat MitraClip therapy in 12 patients.
Before the repeat intervention, median VCA was 66
(IQR: 40 to 96) mm2, clearly indicating the severity
of the recurrent MR. VCA tended to be lower in the
7 patients in whom the repeat intervention was
eventually successful than in the 5 patients in
whom the repeat intervention failed (Table 4). After
the repeat intervention, the median VCA of 68 mm2
in patients with a failed repeat intervention was
clearly indicative of inadequate MR reduction and
markedly larger than in patients with a successful
repeat intervention (22 mm2). VCA after the repeatintervention was >40 mm2 in all 5 patients with
repeat procedural failure, yet in none of the 7 pa-
tients with repeat procedural success (Table 4). Of
note, LLI was present in all of the former patients,
yet in only 1 of the latter.
FOLLOW-UP. The 21 patients were followed for a
median of 8.5 (IQR: 2.3 to 18.6) months after the
repeat MitraClip intervention. Four patients (3 with
LLI, among them 1 with PCD; and 1 with adequate
leaﬂet insertion) underwent mitral valve surgery at a
median of 20 (range 6 to 57) days after the failed
repeat intervention; a ﬁfth patient (with adequate
leaﬂet insertion) underwent mitral valve surgery for
recurrence of signiﬁcant MR 43 days after an initially
successful repeat procedure. Thirteen patients (62%)
died at a median of 3.0 (IQR: 0.7 to 7.9) months after
the repeat MitraClip intervention, among them all
3 patients with functional MR who had under-
gone mitral valve surgery. The 2 patients with
degenerative MR who underwent mitral valve surgery
were alive at 13 and 32 months after the repeat
intervention.
New York Heart Association (NYHA) functional
class was assessed at a median of 28 (IQR: 14 to 45)
months after the repeat intervention in 7 of the 8
surviving patients and revealed NYHA class I/II (n ¼ 2)
and IV (n ¼ 1) in the 3 patients initially treated for
degenerative MR (of whom 2 had LLI) and NYHA class
III in all 4 patients (none with LLI) initially treated for
functional MR.DISCUSSION
MAIN FINDINGS. In this report from a single center
with a large experience in MitraClip treatment of
inoperable or high surgical risk patients, repeat
MitraClip interventions were rare (4.2% incidence)
and occurred at a median of 6.3 months after the
index procedure. Of note, the overall repeat pro-
cedural success rate of 62% contrasted starkly with
the procedural success rate of 91% achieved in 402
index procedures. LLI at the time of the repeat
intervention was strongly associated with inter-
ventional outcome, such that only 25% of repeat
procedures could be successfully completed when
LLI was present, as opposed to 85% repeat inter-
ventional success when leaﬂet insertion was
adequate. Despite the placement of up to 3 new
clips in patients with LLI, the regurgitant oriﬁce as
reﬂected by the VCA could mostly not be reduced
sufﬁciently to qualify the repeat intervention as a
procedural success. In the long term, repeat
TABLE 4 Continued
All Patients
(N ¼ 21)
Successful Repeat
MC Procedure
(n ¼ 13)
Failed Repeat
MC Procedure
(n ¼ 8)
After repeat MC procedure
MR severity
1þ 3 (14.3) 3 (23.1) —
2þ 10 (47.6) 10 (76.9) —
3þ 3 (14.3) — 3 (37.5)
4þ 5 (23.8) — 5 (62.5)
LV end-diastolic diameter, mm 57 [54–75]
(n ¼ 9)
56 [54–61]
(n ¼ 6)
74 [56–78]
(n ¼ 3)
LV end-systolic diameter, mm 52 [44–68]
(n ¼ 8)
49 [44–61]
(n ¼ 6)
62 [38–70]
(n ¼ 2)
LV end-diastolic volume, ml 154 [86–201]
(n ¼ 11)
154 [90–158]
(n ¼ 7)
154 [76–264]
(n ¼ 4)
LV end-systolic volume, ml 97 [38–156]
(n ¼ 11)
97 [48–110]
(n ¼ 7)
103 [27–197]
(n ¼ 4)
LV ejection fraction, % 38 [29–60]
(n ¼ 11)
38 [29–50]
(n ¼ 7)
46 [25–65]
(n ¼ 4)
Mitral valve area (PHT), cm2 1.9 [1.7–2.5]
(n ¼ 14)
2.0 [1.8–2.3]
(n ¼ 9)
1.9 [1.5–2.8]
(n ¼ 5)
Mitral valve area (TEE), cm2 2.6 [2.1–2.7]
(n ¼ 13)
2.5 [2.1–2.6]
(n ¼ 8)
2.7 [2.0–3.1]
(n ¼ 5)
Mean gradient, mm Hg 4.7 [3.1–5.8]
(n ¼ 15)
4.6 [3.1–5.0]
(n ¼ 10)
5.0 [3.0–6.2]
(n ¼ 5)
Systolic PAP, mm Hg 42 [36–52]
(n ¼ 12)
42 [36–52]
(n ¼ 8)
42 [38–51]
(n ¼ 4)
TAPSE, mm 18 [15–19]
(n ¼ 11)
18 [14–18]
(n ¼ 7)
18 [16–19]
(n ¼ 4)
Vena contracta area, mm2 40 [22–59]
(n ¼ 12)
22 [12–37]
(n ¼ 7)
68 [49–80]
(n ¼ 5)
Vena contracta area >40 mm2 7/12 (58.3) 0/7 (0.0) 5/5 (100)
Values are n (%), median [IQR] or n/N (%).
LV ¼ left ventricular; PAP ¼ pulmonary artery pressure; PHT ¼ pressure half-time method; TAPSE ¼ tricuspid
annular plane systolic excursion;TEE¼ transesophageal echocardiography; other abbreviations as inTables 1 and 3.
TABLE 5 Leaﬂet Lengths (mm) at Different Time Points in Patients With LLI
Patient # Leaﬂet Start P1 End P1 Start P2
Inside Clip at
End P1*
Inside Clip at
Start P2†
1 AML 22 15 16 7 6
PML‡ 14 8 9 6 5
2 AML 28 22 22 6 6
PML‡ 15 6 8 9 7
3 AML§ 31 26 25 5 6
PML 9 1 1 8 8
4 AML 36 29 28 7 8
PML‡ 15 8 8 7 7
5 AML§ 35 29 28 6 7
PML 15 9 8 6 7
6 AML 35 27 27 8 8
PML§ 16 8 10 8 6
7 AML 38 31 31 7 7
PML‡ 18 11 11 7 7
Note that at the start of P2, lengths of leaﬂets marked as LT or PCD are the lengths of leaﬂet not
inserting into the clip. *Start P1 minus End P1. †Start P1 minus Start P2. ‡Leaﬂet tear (LT). §Partial
clip detachment (PCD).
AML ¼ anterior mitral leaﬂet; LLI ¼ loss of leaﬂet insertion; P1 ¼ index procedure; P2 ¼ repeat
procedure; PML ¼ posterior mitral leaﬂet.
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1487procedural success appeared to impart a beneﬁcial
effect on survival in patients initially treated for
functional MR.
Index clips had mostly been placed in the central,
mediocentral, and medial valvular region, probably
reﬂecting the predominance of a central regurgitant
jet in patients with mostly functional MR and the
tendency of the investigators to preferentially treat
this condition with centrally and/or mediocentrally
placed clips. During the repeat intervention, the
majority of new clips were also implanted in the
central to medial valvular region; however, almost
30% of new clips were implanted centrolaterally,
possibly indicating a substantial prevalence of
“new” regurgitant ﬂow originating lateral to a cen-
tral index clip.
CLINICAL RELEVANCE. Recurrence of symptomatic
MR after initially successful MitraClip therapy or
aggravation of symptoms requiring treatment after
failed MitraClip therapy may prompt interventional
cardiologists to attempt a repeat MitraClip interven-
tion, because mitral valve surgery had not been an
option in these patients in the ﬁrst place. The present
study has shown that repeat MitraClip implantation
is feasible, particularly in patients with adequate
leaﬂet insertion at the time of the repeat interven-
tion. In such patients, a repeat procedural success
rate on the order of 85% can be expected. However, in
our study, in patients who presented with an echo-
cardiographic pattern of LLI at the time of the repeat
intervention, the chance of repeat procedural success
dropped to 25%.
Our ﬁndings suggest that sufﬁcient leaﬂet coap-
tation is hard to restore if one of the leaﬂets is torn
or perforated—be it “only” with the clip still
attached to the affected leaﬂet, or be it that the
part of the leaﬂet captured by the index clip is
completely ripped out. In our experience, the for-
mer scenario may lend itself to successful repeat
MitraClip intervention, whereas we did not succeed
in repairing any of the 3 PCDs. This is in apparent
contradiction to previous case reports of successful
PCD treatment (10–13). However, it is not known
whether PCDs in those reports were associated with
leaﬂet tear or perforation (it is conceivable that PCD
may also occur as a consequence of inadequate
leaﬂet capture with the gripper barbs not imbedded
in leaﬂet tissue), nor is it known how many PCDs
those authors encountered that could not be treated
successfully.
Despite the fact that LLI had an adverse impact on
the outcome of the repeat intervention, we did not
ﬁnd that it directly affected survival, at least not out
TABLE 6 LV Volumes at Index and Repeat Procedures in In-House Patients Initially
Treated for Functional MR
At Index Procedure At Repeat Procedure
LVEDV, ml
Patients with adequate leaﬂet insertion 124 [107–161]
(n ¼ 5)
170 [129–193]
(n ¼ 6)
Patients with LLI 229 [100–194]
(n ¼ 5)
242 [111–198]
(n ¼ 4)
LVESV, ml
Patients with adequate leaﬂet insertion 70 [67–88]
(n ¼ 5)
120 [87–133]
(n ¼ 6)
Patients with LLI 170 [91–226]
(n ¼ 5)
178 [136–212]
(n ¼ 4)
Values are median [IQR].
LVEDV ¼ left ventricular end-diastolic volume; LVESV ¼ left ventricular end-systolic volume; other
abbreviations as in Tables 1, 3, and 5.
FIGURE 4 Repeat
Clips at the Time of
Loss of leaﬂet insert
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1488to 1 year. Indirectly, though, LLI as a predictor of a
negative procedural outcome did appear to affect
survival: a failed repeat intervention entailed poorer
survival than a successful one, at least in patients
with functional MR.
STUDY LIMITATIONS. Repeat MitraClip intervention
is apparently a rare event. Therefore, the numberProcedural Outcome According to the Status of Leaﬂets and Index
the Repeat Intervention
ion at the time of the repeat intervention was associated with
at procedural success than in patients with adequate leaﬂet insertion.
igure 2.of patients we were able to analyze was small.
As a consequence, predictors of repeat procedural
success in patients with LLI could not be deter-
mined. Strict adherence to a separation of MR
etiologies, with respect to the prevalence of LLI
and repeat procedural outcome would have been
desirable.CONCLUSIONS
Repeat MitraClip intervention for signiﬁcant re-
current MR appears to be a viable therapeutic
approach in patients in whom leaﬂet insertion into
the MitraClip is not compromised. Loss of leaﬂet
insertion as manifested by leaﬂet tear/perforation or
PCD is strongly associated with repeat procedural
failure.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Felix Kreidel, Asklepios Klinik St. Georg, Department
of Cardiology, Lohmühlenstrasse 5, 20099 Hamburg,
Germany. E-mail: f.kreidel@asklepios.com.PERSPECTIVES
WHAT IS KNOWN? In Europe, MitraClip implan-
tation has become the therapy of choice for
patients with signiﬁcant MR who are considered
inoperable or at high operative risk. Reduction in
MR severity persists in the majority of successfully
treated patients; repeat MitraClip intervention may
be considered in cases of signiﬁcant MR
recurrence.
WHAT IS NEW? This study of 21 patients has
shown that repeat MitraClip therapy has a high
chance of success if leaﬂet insertion into the
MitraClip is not compromised. However, LLI, be
it leaﬂet tear/perforation at the site of the clip
or complete detachment of one of the leaﬂets
from the clip, likely entails repeat procedural
failure.
WHAT IS NEXT? Larger numbers of patients
undergoing repeat MitraClip intervention are required
to assess both the prevalence of LLI in different
MR etiologies and predictors of repeat procedural
outcome.
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